Literature DB >> 18556497

Delays in diagnosing cystic fibrosis: can we find ways to diagnose it earlier?

Michelle Steinraths1, Hilary D Vallance, A George F Davidson.   

Abstract

OBJECTIVE: To describe the clinical presentation and delays in diagnosis of patients with cystic fibrosis (CF) with the goal of raising physicians' awareness of CF and establishing baseline data for comparison with outcomes of patients who undergo newborn screening for CF.
DESIGN: Retrospective review of hospital medical records and CF clinic charts of newly diagnosed CF patients younger than 18 years who had attended the CF clinic at the BC Children's Hospital in Vancouver between January 1, 1993, and January 1, 2005. Age at diagnosis of CF was ascertained for 24 adult patients diagnosed during the same period from the CF clinic at St Paul's Hospital in Vancouver, BC.
SETTING: Cystic fibrosis clinic at the BC Children's Hospital. PARTICIPANTS: All newly diagnosed CF patients from mainland BC and northern Vancouver Island (N = 122). MAIN OUTCOME MEASURES: Mean age at diagnosis; mean delay in diagnosis; weight and height or length at diagnosis; vitamin E status; mean head circumference; types of symptoms before diagnosis; Pseudomonas aeruginosa status; and number of days spent in tertiary care hospitals before diagnosis.
RESULTS: Excluding the adult patients and patients with meconium ileus, mean age at diagnosis of CF was 3.6 years, and mean delay in diagnosis after first symptoms was 2.1 years. Weight at diagnosis was < or = 5th percentile in 37% of cases, and height or length was < or = 5th percentile in 26% of cases. Excluding those with meconium ileus and those taking vitamin E supplementation, 70% of the children were vitamin E deficient at diagnosis. These children had a mean head circumference substantially smaller than that of children who had adequate levels of vitamin E. About 95% of children had gastrointestinal (GI) or malnutrition symptoms before diagnosis; 15% had GI symptoms only. About 81% of patients had respiratory symptoms, but only 4% had respiratory symptoms as the only evidence of CF before diagnosis. Around 9% were colonized with P aeruginosa at diagnosis. Before being diagnosed, 79% of patients had required tertiary care hospitalization for a group total of 320 hospital days.
CONCLUSION: Considerable delays in diagnosis of children with CF occur when the disease is identified solely on clinical presentation. Morbidity is often severe enough to require hospital admission before CF is diagnosed. Symptoms that occurred before diagnosis were often GI or malnutritional in nature rather than respiratory, but all such symptoms were associated with diagnostic delays.

Entities:  

Mesh:

Year:  2008        PMID: 18556497      PMCID: PMC2427000     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  27 in total

1.  Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.

Authors:  Don S Lee; Marjorie A Rosenberg; Andrew Peterson; Linda Makholm; Gary Hoffman; Ronald H Laessig; Philip M Farrell
Journal:  J Pediatr       Date:  2003-06       Impact factor: 4.406

2.  Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).

Authors:  D Siret; G Bretaudeau; B Branger; A Dabadie; M Dagorne; V David; M de Braekeleer; V Moisan-Petit; G Picherot; G Rault; V Storni; M Roussey
Journal:  Pediatr Pulmonol       Date:  2003-05

3.  Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis.

Authors:  M Rosenfeld; J Emerson; F Accurso; D Armstrong; R Castile; K Grimwood; P Hiatt; K McCoy; S McNamara; B Ramsey; J Wagener
Journal:  Pediatr Pulmonol       Date:  1999-11

4.  Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients.

Authors:  M E Mérelle; J P Schouten; J Gerritsen; J E Dankert-Roelse
Journal:  Eur Respir J       Date:  2001-08       Impact factor: 16.671

5.  Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.

Authors:  M R Kosorok; L Zeng; S E West; M J Rock; M L Splaingard; A Laxova; C G Green; J Collins; P M Farrell
Journal:  Pediatr Pulmonol       Date:  2001-10

6.  Wasting as an independent predictor of mortality in patients with cystic fibrosis.

Authors:  R Sharma; V G Florea; A P Bolger; W Doehner; N D Florea; A J Coats; M E Hodson; S D Anker; M Y Henein
Journal:  Thorax       Date:  2001-10       Impact factor: 9.139

7.  Cystic fibrosis-related deaths in infancy and the effect of newborn screening.

Authors:  I J Doull; H C Ryley; P Weller; M C Goodchild
Journal:  Pediatr Pulmonol       Date:  2001-05

8.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

Authors:  Julia Emerson; Margaret Rosenfeld; Sharon McNamara; Bonnie Ramsey; Ronald L Gibson
Journal:  Pediatr Pulmonol       Date:  2002-08

9.  Diagnostic delay in cystic fibrosis: lessons from newborn screening.

Authors:  B Wilcken; S J Towns; C M Mellis
Journal:  Arch Dis Child       Date:  1983-11       Impact factor: 3.791

10.  Early versus late diagnosis: psychological impact on parents of children with cystic fibrosis.

Authors:  Maria E Mérelle; Jaap Huisman; Angélika Alderden-van der Vecht; Froukje Taat; Dick Bezemer; Rupino W Griffioen; Govert Brinkhorst; Jeannette E Dankert-Roelse
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

View more
  3 in total

Review 1.  Atypical cystic fibrosis: identification in the primary care setting.

Authors:  Carrie A Schram
Journal:  Can Fam Physician       Date:  2012-12       Impact factor: 3.275

2.  Gender Differences in Clinical Presentations of Cystic Fibrosis Patients in Azeri Turkish Population.

Authors:  Leila Vahedi; Morteza Jabarpoor-Bonyadi; Morteza Ghojazadeh; Amir Vahedi; Mandana Rafeey
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-10-05

3.  Performance of a Three-Tier (IRT-DNA-IRT) Cystic Fibrosis Screening Algorithm in British Columbia.

Authors:  Graham Sinclair; Vanessa McMahon; Amy Schellenberg; Tanya N Nelson; Mark Chilvers; Hilary Vallance
Journal:  Int J Neonatal Screen       Date:  2020-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.